Loading…
Fronto‐parieto‐subthalamic activity decodes motor status in Parkinson's disease
Aims Patients with Parkinson's disease (PD) have various motor difficulties, including standing up, gait initiation and freezing of gait. These abnormalities are associated with cortico‐subthalamic dysfunction. We aimed to reveal the characteristics of cortico‐subthalamic activity in PD patient...
Saved in:
Published in: | CNS neuroscience & therapeutics 2023-07, Vol.29 (7), p.1999-2009 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Aims
Patients with Parkinson's disease (PD) have various motor difficulties, including standing up, gait initiation and freezing of gait. These abnormalities are associated with cortico‐subthalamic dysfunction. We aimed to reveal the characteristics of cortico‐subthalamic activity in PD patients during different motor statuses.
Methods
Potentials were recorded in the superior parietal lobule (SPL), the primary motor cortex (M1), premotor cortex (PMC), and the bilateral subthalamic nucleus (STN) in 18 freely walking patients while sitting, standing, walking, dual‐task walking, and freezing in medication “off” (Moff) and “on” (Mon) states. Different motor status activities were compared in band power, and a machine learning classifier was used to differentiate the motor statuses.
Results
SPL beta power was specifically inhibited from standing to walking, and negatively correlated with walking speed; M1 beta power reflected the degree of rigidity and was reversed by medication; XGBoost algorithm classified the five motor statuses with acceptable accuracy (68.77% in Moff, 60.58% in Mon). SPL beta power ranked highest in feature importance in both Moff and Mon states.
Conclusion
SPL beta power plays an essential role in walking status classification and could be a physiological biomarker for walking speed, which would aid the development of adaptive DBS.
This study showed SPL beta power indicated the physiological walking activities both in the medication “off” and “on” states, and beta power in M1 reflected the degree of rigidity and could be reserved by medication. These findings provide evidence for decoding PD patients' movements and sheds new insight into the development of intelligent closed‐loop DBS. |
---|---|
ISSN: | 1755-5930 1755-5949 |
DOI: | 10.1111/cns.14155 |